Akebia Saponin D Targeting Ubiquitin Carboxyl-Terminal Hydrolase 4 Promotes Peroxisome Proliferator-Activated Receptor Gamma Deubiquitination and Activation of Brown Adipose Tissue Thermogenesis in Obesity

Abstract

Promoting thermogenesis in adipose tissue to enhance energy expenditure is widely regarded as a promising strategy for obesity treatment. However, the development of effective thermogenic drugs remains challenging. Our screenings identified the natural compound Akebia Saponin D (ASD) as a potent brown fat thermogenesis activator in mice, showing effects through mitochondrial brown fat uncoupling protein 1 (UCP1)-dependent pathways. ASD was found to significantly mitigate high-fat diet-induced obesity and enhance the mitochondrial quality of brown adipocytes to promote thermogenesis. Utilizing human protein microarrays, cellular thermal shift assay, and drug affinity responsive target stability, along with microscale thermophoresis and molecular docking analysis, we identified ubiquitin carboxyl-terminal hydrolase 4 (USP4) as a direct target of ASD. ASD interacts with USP4 and promotes the deubiquitination of peroxisome proliferator-activated receptor gamma, thus inhibiting its proteasomal degradation and enhancing the transcriptional activation of UCP1 in brown adipocytes. Additionally, USP4 knockdown was shown to attenuate brown fat thermogenesis induced by ASD. In summary, our findings demonstrate that ASD promotes brown fat thermogenesis by targeting USP4, highlighting its potential as a promising natural small molecule for obesity treatment.

Keywords

Akebia Saponin D / deubiquitination / mitochondria / obesity / ubiquitin carboxyl-terminal hydrolase 4

References

[1] T. Montanari, N. Pošćić, and M. Colitti, “Factors Involved in White-to-brown Adipose Tissue Conversion and in Thermogenesis: A Review,” Obesity Reviews 18, no. 5 (2017): 495-513.

[2] M. Blüher, “Obesity: Global Epidemiology and Pathogenesis,” Nature Reviews Endocrinology 15, no. 5 (2019): 288-298.

[3] A. Sakers, M. K. De Siqueira, P. Seale, and C. J. Villanueva, “Adipose-tissue Plasticity in Health and Disease,” Cell 185, no. 3 (2022): 419-446.

[4] P. Lee, “Wasting Energy to Treat Obesity,” New England Journal of Medicine 375, no. 23 (2016): 2298-2300.

[5] I. Szabo and M. Zoratti, “Now UCP(rotein), Now You Don't: UCP1 Is Not Mandatory for Thermogenesis,” Cell Metabolism 25, no. 4 (2017): 761-762.

[6] L. P. Kozak, J. H. Britton, U. C. Kozak, and J. M. Wells, “The Mitochondrial Uncoupling Protein Gene. Correlation of Exon Structure to Transmembrane Domains,” Journal of Biological Chemistry 263, no. 25 (1988): 12274-12277.

[7] J. Nedergaard, V. Golozoubova, A. Matthias, A. Asadi, A. Jacobsson, and B. Cannon, “UCP1: The Only Protein Able to Mediate Adaptive Non-shivering Thermogenesis and Metabolic Inefficiency,” Biochimica Et Biophysica Acta 1504, no. 1 (2001): 82-106.

[8] B. Cannon and J. Nedergaard, “Brown Adipose Tissue: Function and Physiological Significance,” Physiological Reviews 84, no. 1 (2004): 277-359.

[9] E. T. Chouchani, L. Kazak, and B. M. Spiegelman, “New Advances in Adaptive Thermogenesis: UCP1 and Beyond,” Cell Metabolism 29, no. 1 (2019): 27-37.

[10] A. M. Cypess, S. Lehman, G. Williams, et al., “Identification and Importance of Brown Adipose Tissue in Adult Humans,” New England Journal of Medicine 360, no. 15 (2009): 1509-1517.

[11] W. D. van Marken Lichtenbelt, J. W. Vanhommerig, N. M. Smulders, et al., “Cold-activated Brown Adipose Tissue in Healthy Men,” New England Journal of Medicine 360, no. 15 (2009): 1500-1508.

[12] T. Becher, S. Palanisamy, D. J. Kramer, et al., “Brown Adipose Tissue Is Associated With Cardiometabolic Health,” Nature Medicine 27, no. 1 (2021): 58-65.

[13] A. Bartelt, O. T. Bruns, R. Reimer, et al., “Brown Adipose Tissue Activity Controls Triglyceride Clearance,” Nature Medicine 17, no. 2 (2011): 200-205.

[14] M. Okla, J. Kim, K. Koehler, and S. Chung, “Dietary Factors Promoting Brown and Beige Fat Development and Thermogenesis,” Advances in Nutrition 8, no. 3 (2017): 473-483.

[15] S. Kajimura, P. Seale, K. Kubota, et al., “Initiation of Myoblast to Brown Fat Switch by a PRDM16-C/EBP-beta Transcriptional Complex,” Nature 460, no. 7259 (2009): 1154-1158.

[16] J. Y. Altarejos and M. Montminy, “CREB and the CRTC co-activators: Sensors for Hormonal and Metabolic Signals,” Nature Reviews Molecular Cell Biology 12, no. 3 (2011): 141-151.

[17] W. Cao, K. W. Daniel, J. Robidoux, et al., “p38 mitogen-activated Protein Kinase Is the central Regulator of Cyclic AMP-dependent Transcription of the Brown Fat Uncoupling Protein 1 Gene,” Molecular and Cellular Biology 24, no. 7 (2004): 3057-3067.

[18] P. Puigserver, Z. Wu, C. W. Park, R. Graves, M. Wright, and B. M. Spiegelman, “A Cold-inducible Coactivator of Nuclear Receptors Linked to Adaptive Thermogenesis,” Cell 92, no. 6 (1998): 829-839.

[19] V. Hainer, “Beta3-adrenoreceptor Agonist Mirabegron—a Potential Antiobesity Drug?,” Expert Opinion on Pharmacotherapy 17, no. 16 (2016): 2125-2127.

[20] D. P. Blondin, S. Nielsen, E. N. Kuipers, et al., “Human Brown Adipocyte Thermogenesis Is Driven by beta2-AR Stimulation,” Cell Metabolism 32, no. 2 (2020): 287-300. e7.

[21] M. Ahmadian, J. M. Suh, N. Hah, et al., “PPARγ Signaling and Metabolism: The Good, the Bad and the Future,” Nature Medicine 19, no. 5 (2013): 557-566.

[22] C. Vernochet, S. B. Peres, K. E. Davis, et al., “C/EBPalpha and the Corepressors CtBP1 and CtBP2 Regulate Repression of Select Visceral White Adipose Genes During Induction of the Brown Phenotype in White Adipocytes by Peroxisome Proliferator-activated Receptor Gamma Agonists,” Molecular and Cellular Biology 29, no. 17 (2009): 4714-4728.

[23] R. Brunmeir and F. Xu, “Functional Regulation of PPARs Through Post-Translational Modifications,” International Journal of Molecular Sciences 19, no. 6 (2018): 1738.

[24] O. van Beekum, V. Fleskens, and E. Kalkhoven, “Posttranslational Modifications of PPAR-gamma: Fine-tuning the Metabolic Master Regulator,” Obesity (Silver Spring) 17, no. 2 (2009): 213-219.

[25] L. Qiang, L. Wang, N. Kon, et al., “Brown Remodeling of White Adipose Tissue by SirT1-dependent Deacetylation of Pparγ,” Cell 150, no. 3 (2012): 620-632.

[26] K. D. Wilkinson, “Ubiquitin: A Nobel Protein,” Cell 119, no. 6 (2004): 741-745.

[27] C. M. Pickart, “Mechanisms Underlying Ubiquitination,” Annual Review of Biochemistry 70 (2001): 503-533.

[28] D. Komander, M. J. Clague, and S. Urbé, “Breaking the Chains: Structure and Function of the Deubiquitinases,” Nature Reviews Molecular Cell Biology 10, no. 8 (2009): 550-563.

[29] K. Gupta, N. G. Copeland, D. J. Gilbert, N. A. Jenkins, and D. A. Gray, “Unp, a Mouse Gene Related to the Tre Oncogene,” Oncogene 8, no. 8 (1993): 2307-2310.

[30] Y. Zhao, F. Wang, L. Gao, et al., “Ubiquitin-Specific Protease 4 Is an Endogenous Negative Regulator of Metabolic Dysfunctions in Nonalcoholic Fatty Liver Disease in Mice,” Hepatology 68, no. 3 (2018): 897-917.

[31] J. Yao, D. Wu, C. Zhang, et al., “Macrophage IRX3 Promotes Diet-induced Obesity and Metabolic Inflammation,” Nature Immunology 22, no. 10 (2021): 1268-1279.

[32] L. L. Gong, S. Yang, H. Liu, et al., “Anti-nociceptive and Anti-inflammatory Potentials of Akebia Saponin D,” European Journal of Pharmacology 845 (2019): 85-90.

[33] J. F. Luo, H. Zhou, and C. K. Lio, “Akebia Saponin D Inhibits the Inflammatory Reaction by Inhibiting the IL-6-STAT3-DNMT3b Axis and Activating the Nrf2 Pathway,” Molecules (Basel, Switzerland) 27, no. 19 (2022): 6236.

[34] Z. Sun, J. Gong, H. Wu, et al., “Perilipin1 promotes Unilocular Lipid Droplet Formation Through the Activation of Fsp27 in Adipocytes,” Nature Communications 4 (2013): 1594.

[35] B. W. Parks, E. Nam, and E. Org, “Genetic Control of Obesity and Gut Microbiota Composition in Response to High-fat, High-sucrose Diet in Mice,” Cell Metabolism 17, no. 1 (2013): 141-152.

[36] Y. Mao, W. Wang, and J. Yang, “Drug Repurposing Screening and Mechanism Analysis Based on human Colorectal Cancer Organoids,” Protein Cell 15, no. 4 (2024): 285-304.

[37] E. N. Kuipers, N. M. Held, W. In Het Panhuis, et al., “A Single Day of High-fat Diet Feeding Induces Lipid Accumulation and Insulin Resistance in Brown Adipose Tissue in Mice,” American Journal of Physiology Endocrinology and Metabolism 317, no. 5 (2019): E820-e830.

[38] Y. B. Niu, Y. H. Li, X. H. Kong, et al., “The Beneficial Effect of Radix Dipsaci Total Saponins on Bone Metabolism in Vitro and in Vivo and the Possible Mechanisms of Action,” Osteoporosis International 23, no. 11 (2012): 2649-2660.

[39] Y. Niu, C. Li, Y. Pan, et al., “Treatment of Radix Dipsaci Extract Prevents Long Bone Loss Induced by Modeled Microgravity in Hindlimb Unloading Rats,” Pharmaceutical Biology 53, no. 1 (2015): 110-116.

[40] S. Yang, T. Hu, H. Liu, et al., “Akebia Saponin D Ameliorates Metabolic Syndrome (MetS) via Remodeling Gut Microbiota and Attenuating Intestinal Barrier Injury,” Biomedicine & Pharmacotherapy 138 (2021): 111441.

[41] L. L. Gong, G. R. Li, W. Zhang, et al., “Akebia Saponin D Decreases Hepatic Steatosis Through Autophagy Modulation,” Journal of Pharmacology and Experimental Therapeutics 359, no. 3 (2016): 392-400.

[42] Y. Shu, X. Yang, L. Wei, et al., “Akebia Saponin D From Dipsacus Asper Wall. Ex C.B. Clarke Ameliorates Skeletal Muscle Insulin Resistance Through Activation of IGF1R/AMPK Signaling Pathway,” Journal of Ethnopharmacology 318, no. Pt B (2024): 117049.

[43] J. Zhang, S. Yi, C. Xiao, et al., “Asperosaponin VI Inhibits LPS-induced Inflammatory Response by Activating PPAR-γ Pathway in Primary Microglia,” Saudi Journal of Biological Sciences 27, no. 11 (2020): 3138-3144.

[44] M. Naesens and M. M. Sarwal, “Molecular Diagnostics in Transplantation,” Nature Reviews Nephrology 6, no. 10 (2010): 614-628.

[45] M. M. Ibrahim, “Subcutaneous and Visceral Adipose Tissue: Structural and Functional Differences,” Obesity Reviews 11, no. 1 (2010): 11-18.

[46] N. Pescador, V. Francisco, P. Vazquez, et al., “Metformin Reduces Macrophage HIF1alpha-dependent Proinflammatory Signaling to Restore Brown Adipocyte Function in Vitro,” Redox Biology 48 (2021): 102171.

[47] M. Di Michele, E. Stes, E. Vandermarliere, et al., “Limited Proteolysis Combined With Stable Isotope Labeling Reveals Conformational Changes in Protein (Pseudo)Kinases Upon Binding Small Molecules,” Journal of Proteome Research 14, no. 10 (2015): 4179-4193.

[48] T. Inagaki, J. Sakai, and S. Kajimura, “Transcriptional and Epigenetic Control of Brown and Beige Adipose Cell Fate and Function,” Nature Reviews Molecular Cell Biology 17, no. 8 (2016): 480-495.

[49] N. Chen, M. Zhao, N. Wu, et al., “ACSS2 controls PPARγ Activity Homeostasis to Potentiate Adipose-tissue Plasticity,” Cell Death and Differentiation 31, no. 4 (2024): 479-496.

[50] J. Jiang, D. Zhou, A. Zhang, et al., “Thermogenic Adipocyte-derived Zinc Promotes Sympathetic Innervation in Male Mice,” Nature Metabolism 5, no. 3 (2023): 481-494.

[51] P. Cohen and S. Kajimura, “The Cellular and Functional Complexity of Thermogenic Fat,” Nature Reviews Molecular Cell Biology 22, no. 6 (2021): 393-409.

[52] X. Jiang, M. Yu, Y. Ou, et al., “Downregulation of USP4 Promotes Activation of Microglia and Subsequent Neuronal Inflammation in Rat Spinal Cord after Injury,” Neurochemical Research 42, no. 11 (2017): 3245-3253.

[53] Y. Zhang, J. Wan, Z. Xu, T. Hua, and Q. Sun, “Exercise Ameliorates Insulin Resistance via Regulating TGFβ-activated Kinase 1 (TAK1)-mediated Insulin Signaling in Liver of High-fat Diet-induced Obese Rats,” Journal of Cellular Physiology 234, no. 5 (2019): 7467-7474.

[54] B. W. Parks, T. Sallam, M. Mehrabian, et al., “Genetic Architecture of Insulin Resistance in the Mouse,” Cell Metabolism 21, no. 2 (2015): 334-347.

[55] M. M. Seldin, S. Koplev, P. Rajbhandari, et al., “A Strategy for Discovery of Endocrine Interactions With Application to Whole-Body Metabolism,” Cell Metabolism 27, no. 5 (2018): 1138-1155. e6.

[56] J. Zhang, S. Yi, C. Xiao, et al., “Asperosaponin VI Inhibits LPS-induced Inflammatory Response by Activating PPAR-gamma Pathway in Primary Microglia,” Saudi Journal of Biological Sciences 27, no. 11 (2020): 3138-3144.

[57] H. You, P. Chu, W. Guo, and B. Lu, “A Subpopulation of Bdnf-e1-expressing Glutamatergic Neurons in the Lateral Hypothalamus Critical for Thermogenesis Control,” Molecular Metabolism 31 (2020): 109-123.

[58] M. Escudero, L. Vaysse, G. Eke, et al., “Scalable Generation of Pre-Vascularized and Functional Human Beige Adipose Organoids,” Advanced Science (Weinheim) 10, no. 31 (2023): e2301499.

[59] A. Ventura, A. Meissner, C. P. Dillon, et al., “Cre-lox-regulated Conditional RNA Interference From Transgenes,” Proceeding of the National Academy of Sciences of the United States of America 101, no. 28 (2004): 10380-10385.

RIGHTS & PERMISSIONS

2025 The Author(s). MedComm published by Sichuan International Medical Exchange & Promotion Association (SCIMEA) and John Wiley & Sons Australia, Ltd.